2 contrasting medtech approaches to deal with chronic pain and avoid opioids
DHIT2017-09-19T09:42:00-04:00By ARUNDHATI PARMAR | Sep 18, 2017 As the nation battles the opioid crisis, medtech companies are relying on versions of a technology that they hope will make a real dent in how chronic pain is treated and managed: neurostimulation. On Monday, Medtronic announced that FDA has approved its Intellis implantable spinal cord stimulation system to treat chronic, [...]